Floatz logo

Therapeutic Asset Ratings

193 results matching 1 filter

133,990 assets · 8,802 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Favezelimab
Endometrial Cancer
Merck Sharp & Dohme LLCP2CCC (51)
Serabelisib
Endometrial Cancer
Faeth TherapeuticsP2CCC (51)
Tas-102
Endometrial Cancer
National Cancer Institute (NCI)P2CCC (51)
[18f]f-resca-rt4
Endometrial Cancer
RenJi HospitalP2/3CCC (50)
[18F]F-RESCA-T4
Endometrial Cancer
RenJi HospitalP2/3CCC (50)
[68ga]ga-nota-rt4
Endometrial Cancer
RenJi HospitalP2/3CCC (50)
[68ga]ga-nota-t4
Endometrial Cancer
RenJi HospitalP2/3CCC (50)
pf-05212384
Endometrial Cancer
Dana-Farber Cancer InstituteP2CCC (49)
Aprotinin
Endometrial Cancer
Sun Yat-sen UniversityP2CCC (48)
Belzutifan
Endometrial Cancer
Dana-Farber Cancer InstituteP2CCC (48)
CHLOROPTIC-P S.O.P. COMPONENT PREDNISOLONE
Endometrial Cancer
AstraZenecaP2CCC (48)
Copanlisib
Endometrial Cancer
M.D. Anderson Cancer CenterP2CCC (48)
her3-dxd
Endometrial Cancer
Daiichi SankyoP2CCC (48)
hs-20089
Endometrial Cancer
Hansoh BioMedical R&D CompanyP2CCC (48)
Lorigerlimab
Endometrial Cancer
MacroGenicsP2CCC (48)
ly3023414
Endometrial Cancer
Dana-Farber Cancer InstituteP2CCC (48)
PREDNISONE TABLETS
Endometrial Cancer
AstraZenecaP2CCC (48)
Pyruvate
Endometrial Cancer
Chang Gung Memorial HospitalP2CCC (48)
(R)-(1-(4-FLUOROPHENYL)-6-((1-METHYL-1H-PYRAZOL-4-YL)SULFONYL)-1,4,5,6,7,8-HEXAHYDRO-4AH-PYRAZOLO(3,4-G)ISOQUINOLIN-4A-YL)(4-(TRIFLUOROMETHYL)PYRIDIN-2-YL)METHANONE
Endometrial Cancer
Corcept TherapeuticsP2CCC (48)
Tak-228
Endometrial Cancer
Faeth TherapeuticsP2CCC (48)
Trilaciclib
Endometrial Cancer
Sun Yat-sen UniversityP2CCC (48)
Volrustomig
Endometrial Cancer
AstraZenecaP2CCC (48)
Zanidatamab
Endometrial Cancer
Jazz PharmaceuticalsP2CCC (48)
Dordaviprone
Endometrial Cancer
UNC Lineberger Comprehensive Cancer CenterP2CC (47)
LEUPROLIDE
Endometrial Cancer
Avenzo Therapeutics, Inc.P1/2CC (46)
Showing 51 to 75 of 193 assets
PreviousPage 3 of 8Next